Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery
NCT01936233 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 112
Last updated 2019-08-05
Summary
Evaluation the Treatment Outcome of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery.
Conditions
- Hepatocellular Carcinoma
- Recurrence
Interventions
- DRUG
-
Aspirin 0.1 QD po
- DRUG
-
Lamivudine
LAminvudine 0.1 QD po
Sponsors & Collaborators
-
Fudan University
lead OTHER
Principal Investigators
-
Zhenggang Ren, Ph.D · Fudan University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2021-12-31
- Completion
- 2023-12-31
Countries
- China
Study Locations
More Related Trials
-
Study on Screening, Verification and Intervention of High-risk Patients With Liver Cancer
NCT05721300 ·Status: UNKNOWN ·Phase: NA
-
Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer
NCT00238160 ·Status: WITHDRAWN ·Phase: PHASE3
-
The Utility of Cell-free DNA Methylation Markers for Hepatocellular Carcinoma
NCT05573217 ·Status: UNKNOWN
-
Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma
NCT01328223 ·Status: UNKNOWN
-
Post-Radical Treatment Antiviral Strategies in HBV-Related Liver Cancer: Impact on Tumor Prognosis
NCT07120750 ·Status: NOT_YET_RECRUITING
-
Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy
NCT00933816 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative Resection
NCT04032860 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC
NCT02018757 ·Status: UNKNOWN ·Phase: PHASE2
-
Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma
NCT01861912 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efcacy and Safety of Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With mFOLFOX in Hepatocellular Carcinoma With High-risk Recurrence Factors
NCT07337421 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Hepatectomy on the Prognosis of Patients With Nasopharyngeal Carcinoma Liver Metastases
NCT05771025 ·Status: RECRUITING ·Phase: NA
-
Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection
NCT00561522 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma Patient
NCT02338778 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Liver Cancer
NCT02447263 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Beyond Milan Criteria BCLC Stage A/B Hepatocellular Carcinoma Who Underwent Hepatectomy
NCT03851913 ·Status: UNKNOWN ·Phase: PHASE3
-
Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma
NCT00555334 ·Status: UNKNOWN ·Phase: PHASE4
-
Sorafenib Combined With Arsenical in Treating Patients With Recurrent HCC After Liver Transplantation
NCT04232722 ·Status: UNKNOWN ·Phase: PHASE2
-
Circulating Tumor Cell Capture for Early Diagnosis and Postoperative Tumor Recurrence Monitoring of Liver Cancer
NCT04688606 ·Status: UNKNOWN
-
The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma
NCT01055743 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer
NCT04329429 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma
NCT02586285 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery
NCT06762782 ·Status: RECRUITING ·Phase: PHASE2
-
Bioinformation Therapy for Liver Cancer
NCT03239158 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Anti-angiogenesis Combined With PD-1/PD-L1 Therapy in Patients With Advanced Liver Cancer
NCT05383066 ·Status: UNKNOWN
-
Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis
NCT02634502 ·Status: UNKNOWN ·Phase: PHASE2